Congenital Hematological Disorder Withdrawn Phase 1 Trials for Coagulation factor VIIa Recombinant Human (DB00036)

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02084810Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male SubjectsTreatment